Smithfield Trust’s Moderna MRNA Stock Holding History

Smithfield Trust’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20	Closed	-$1K	–	1058
2025 Q1	$1K	Hold	20	–	–	﹤0.01%	1033
2024 Q4	$1K	Hold	20	–	–	﹤0.01%	1041
2024 Q3	$1K	Hold	20	–	–	﹤0.01%	1008
2024 Q2	$2K	Hold	20	–	–	﹤0.01%	974
2024 Q1	$2K	Hold	20	–	–	﹤0.01%	1012
2023 Q4	$2K	Sell	20 -90	-82%	-$7.57K	﹤0.01%	983
2023 Q3	$11K	Buy	110 +90	+450%	+$10K	﹤0.01%	795
2023 Q2	$2K	Hold	20	–	–	﹤0.01%	993
2023 Q1	$3K	Hold	20	–	–	﹤0.01%	942
2022 Q4	$4K	Hold	20	–	–	﹤0.01%	912
2022 Q3	$2K	Hold	20	–	–	﹤0.01%	1016
2022 Q2	$3K	Hold	20	–	–	﹤0.01%	1009
2022 Q1	$3K	Hold	20	–	–	﹤0.01%	1034
2021 Q4	$5K	Sell	20 -53	-73%	-$15.5K	﹤0.01%	990
2021 Q3	$28K	Hold	73	–	–	﹤0.01%	653
2021 Q2	$17K	Hold	73	–	–	﹤0.01%	730
2021 Q1	$10K	Hold	73	–	–	﹤0.01%	843
2020 Q4	$8K	Hold	73	–	–	﹤0.01%	875
2020 Q3	$5K	Hold	73	–	–	﹤0.01%	934
2020 Q2	$4K	Buy	+73	New	+$4K	﹤0.01%	885

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Smithfield Trust's MRNA Position: Q2 2025 in Review

Smithfield Trust sold out of Moderna (MRNA) in Q2 2025, closing a stake of 20 shares — an estimated $1K sold.

Smithfield Trust first reported a position in MRNA in Q2 2020 and held it in 20 quarters. The position peaked at $28K in Q3 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

Smithfield Trust reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
Smithfield Trust sold 20 Moderna shares in Q2 2025, an estimated $1K.
Smithfield Trust first reported a position in Moderna in Q2 2020 and held it in 20 quarters.
Smithfield Trust's Moderna position peaked at $28K in Q3 2021.
674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Smithfield Trust's 13F filing for Q2 2025, filed 8 Aug 2025.